Literature DB >> 18997759

What's fueling the biotech engine-2007.

Saurabh Aggarwal1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18997759     DOI: 10.1038/nbt1108-1227

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  What's fueling the biotech engine--2010 to 2011.

Authors:  Saurabh Aggarwal
Journal:  Nat Biotechnol       Date:  2011-12-08       Impact factor: 54.908

2.  What's fueling the biotech engine-2009-2010.

Authors:  Saurabh Aggarwal
Journal:  Nat Biotechnol       Date:  2010-11       Impact factor: 54.908

3.  What's fueling the biotech engine--2008.

Authors:  Saurabh Aggarwal
Journal:  Nat Biotechnol       Date:  2009-11       Impact factor: 54.908

4.  Aggregation stability of a monoclonal antibody during downstream processing.

Authors:  Paolo Arosio; Giuliano Barolo; Thomas Müller-Späth; Hua Wu; Massimo Morbidelli
Journal:  Pharm Res       Date:  2011-03-30       Impact factor: 4.200

Review 5.  Pharmacokinetics of recombinant bifunctional fusion proteins.

Authors:  Xiaoying Chen; Jennica L Zaro; Wei-Chiang Shen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-03-20       Impact factor: 4.481

6.  Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.

Authors:  Paolo Arosio; Simonetta Rima; Massimo Morbidelli
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

7.  What's fueling the biotech engine-2012 to 2013.

Authors:  Rob Saurabh Aggarwal
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

8.  Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.

Authors:  Darius Ghaderi; Rachel E Taylor; Vered Padler-Karavani; Sandra Diaz; Ajit Varki
Journal:  Nat Biotechnol       Date:  2010-07-25       Impact factor: 54.908

9.  Study on the effect of solution conditions on heat induced-aggregation of human alpha interferon.

Authors:  Faranak Salmannejad; Nastaran Nafissi-Varcheh; Alireza Shafaati; Reza Aboofazeli
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.